April 1, 2021 | Cancer starts with mutations in a cell’s DNA, but new UC San Francisco research shows that the endurance of a tumor relies on its ability to rapidly evolve and adapt to challenges brought about by the environment in which it grows.
March 22, 2021 | A panel of health experts and government officials addressed the myriad issues related to COVID-19, including health disparities before and during the pandemic, public partnerships, and how communities can better address inequities to prevent the next crisis.
March 16, 2021 | One year after the declaration of the pandemic and San Franciscoʻs shelter-in-place order, members from every corner of the Cancer Center shared their lessons learned on change, adaptation, and resilience.
March 1, 2021 | In commemoration of the 50th Anniversary of the National Cancer Act, the Division of Cancer Prevention honors Christine Miaskowski, RN, PhD, FAAN, as a champion and changemaker of cancer prevention, early detection and symptom science.
February 17, 2021 | Women in academic medicine are facing the prospect of career setbacks as a result of the COVID-19 pandemic. A recently published Viewpoint article in JAMA Oncology by UCSF physician-scientists addressed the issue and offered solutions for institutions.
February 12, 2021 | Many cancer patients might respond better to treatments with the help of a new prognostic indicator based on a distinctive pattern of gene activity within tumor cells, according to a new study of human cancer data and experiments on human cancer cell lines grown in the lab.
February 11, 2021 | Source: UCSF.edu. A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.